Mohamed Abu-Farha
Mohamed Abu-Farha is an expert in Endocrinology at Dasman Diabetes Institute (Kuwait). As of October 2026, ScienceLeadR ranks Mohamed Abu-Farha in the top 1% of experts worldwide for Obesity, Diabetes Mellitus and Glucose Metabolism Disorders. Mohamed Abu-Farha has authored 208 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 2 of them ongoing. SLR score: 799 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Biochemistry - Nephrology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2007 - 2026
Number : 208
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Prevalence and steatosis severity of MASLD in patients with type 2 diabetes mellitus in Kuwait. PMID 42947715 — liver diseases, diabetes mellitus, fibrosis, metabolic diseases, liver, prevalence, fatty liver, diabetes mellitus, type 2 | Front Endocrinol (Lausanne) | 2026 | 0 |
| Associations of Elevated Lipoprotein(a) with C-Reactive Protein and Type 2 Diabetes in a Multiethnic Population. PMID 42792739 — diabetes mellitus, lipoproteins, c-reactive protein, cardiovascular diseases, dyslipidemias, prevalence, lipoprotein(a), diabetes mellitus, type 2 | Biomedicines | 2026 | 0 |
| Obstructive sleep apnea risk is associated with a diminished cognitive profile: findings from the Canadian longitudinal study on aging. PMID 42741430 — diabetes mellitus, longitudinal studies, sleep apnea, obstructive, aging, sleep, apnea, discriminant analysis, cognitive dysfunction, cognition disorders, sex, sleep apnea syndromes, memory, sleep initiation and maintenance disorders, canadian longitudinal study on aging | Front Psychol | 2026 | 0 |
| Sleeve Gastrectomy Reverses Hepatic and Circulating Transcriptomic Dysregulation by Restoring Lipid and Energy Metabolism in a Diet-Induced MASLD Rats. PMID 42684983 — genes, insulin, leptin, polymerase chain reaction, diet, obesity, gastrectomy, peroxisome proliferator-activated receptors, fatty acids | Med Princ Pract | 2026 | 0 |
| Circulating IGFBP-7 in Obstructive Sleep Apnea: A Single-Cohort Preliminary Assessment of Its Diagnostic Performance and Post-Treatment Dynamics. PMID 42652163 — sleep apnea, obstructive, sleep, apnea, multiple chronic conditions, biomarkers, insulin-like growth factor binding proteins, hypoxia, obesity, sleep apnea syndromes, diagnosis, therapeutics | Biomedicines | 2026 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration NCT06922656 — diabetes mellitus, sodium-glucose transporter 2 inhibitors, insulin, pharmaceutical preparations, ketones, pioglitazone, counterfeit drugs, therapeutics, hypoglycemia, diabetes mellitus, type 1, plasma, ketosis | Phase 4 | Not yet recruiting | 2025 |
| Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) Program NCT06115876 — liver diseases, diabetes mellitus, epidemiology, non-alcoholic fatty liver disease, glucose intolerance, liver, alcoholics, prediabetic state, obesity, risk factors, research, fatty liver, diabetes mellitus, type 1, fatty liver, alcoholic, diabetes mellitus, type 2 | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map